1) Strong Q1 Performance and Growth Outlook
- Waters Corporation reported Q1 2026 revenue of $1.267 billion, with $747 million from organic revenue and $520 million from newly acquired Biosciences and Diagnostic Solutions. - Organic revenue grew 13% as reported and 11% in constant currency, exceeding guidance by 200 basis points. - Adjusted EPS increased by 20% to $2.70, surpassing expectations by $0.35. - The company raised its full-year organic revenue growth guidance to 6.5% to 8%, reflecting strong momentum and embedding $15 million of expected revenue synergies.

2) Segment Performance Highlights
- Analytical Sciences division grew 12% in constant currency, driven by strong instrument replacement and new product adoption. - Biosciences revenue was $230 million, with a 7% estimated growth, showing improvement from previous quarters. - Advanced Diagnostics division reported $288 million in revenue, reflecting 8% growth, with microbiology growing 10%. - Material Sciences division achieved $79 million, up 6%, with growth in high-growth applications like batteries and aerospace.

3) Operational Improvements and Integration Success
- The integration of the Biosciences and Diagnostic Solutions businesses is progressing well, with a 180-day plan implemented to drive operational improvements and revenue synergies. - Early results indicate increased commercial activity, improved pricing discipline, and enhanced customer engagement. - The company is localizing manufacturing in China to improve market access and address share loss in Flow research.

4) Challenges and Headwinds
- There were $20 million in headwinds from respiratory testing due to a weak flu season, impacting overall growth. - The company faces ongoing challenges in the Chinese market, including export restrictions and the need for a localized product portfolio. - Despite these challenges, the management remains optimistic about overcoming them through strategic initiatives and product launches.

5) Guidance and Future Outlook
- For Q2 2026, Waters expects organic constant currency revenue growth of 6% to 8%, with total reported revenue guidance of $1.616 billion to $1.631 billion. - Adjusted EPS for Q2 is projected to be between $2.95 and $3.05. - The company anticipates continued strong performance driven by the instrument replacement cycle and operational improvements, with a focus on achieving at least 100 basis points of adjusted operating margin expansion annually through the end of the decade.

Bottom line: Waters Corporation's strong Q1 results and raised guidance reflect successful integration and operational improvements post-acquisition, positioning the company for sustained growth despite facing some headwinds. Shareholders can expect continued momentum and value creation as the company executes its strategic initiatives.